Navigation Links
The law firms of Bernstein Litowitz Berger & Grossmann LLP and Labaton Sucharow LLP announce pendency of class action in In re Schering-Plough Corporation / ENHANCE Securities Litigation
Date:1/25/2013

NEW YORK, Jan. 25, 2013 /PRNewswire/ --

UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF NEW JERSEY 

IN RE SCHERING-PLOUGH CORPORATION /ENHANCE SECURITIES LITIGATION 

Civil Action No. 08-397 (DMC) (JAD)

 SUMMARY NOTICE OF PENDENCY OF CLASS ACTIONTo: All persons and entities that purchased or acquired Schering-Plough Corporation ("Schering") common stock, 6% mandatory convertible preferred stock maturing August 13, 2010 ("Preferred Stock"), or call options, and/or sold Schering put options, during the period between January 3, 2007 through and including March 28, 2008, and who did not sell their stock and/or options on or before December 11, 2007, and who were damaged thereby (the "Class").YOU ARE HEREBY NOTIFIED, pursuant to Rule 23 of the Federal Rules of Civil Procedure and an Order of the United States District Court for the District of New Jersey, that the above-captioned action (the "Action") has been certified as a class action.

IF YOU ARE A MEMBER OF THE CLASS, YOUR RIGHTS WILL BE AFFECTED BY THIS ACTION. A full printed Notice of Pendency of Class Action is currently being mailed to known Class Members. If you have not yet received a full printed Notice, you may obtain copies of this document by downloading it from www.scheringvytorinsecuritieslitigation.com or by contacting the Notice Administrator:

In re Schering-Plough Corporation / ENHANCE Securities Litigation
P.O. Box 3127
Portland, OR 97208-3127
(877) 854-4458

If you did not receive the Notice by mail, and you are and decide to remain a member of the Class, please send your name and address to the Notice Administrator so that if any further notices are disseminated in connection with the Action, you will receive them.

Inquiries, other than requests for the Notice, may be made to Class Counsel:

Salvatore J. Graziano

Christopher J. McDonaldBERNSTEIN LITOWITZLABATON SUCHAROW LLPBERGER & GROSSMANN LLP140 Broadway1285 Avenue of the Americas

New York, NY 10005New York, NY 10019

(212) 907-0700(800) 380-8496If you are a Class Member, you have the right to decide whether to remain a member of the Class. If you choose to remain a member of the Class, you do not need to do anything at this time other than to retain your documentation reflecting your transactions and holdings in Schering common stock, Preferred Stock, and options during the period from January 3, 2007 through and including March 28, 2008. You will automatically be included in the Class. If you are a Class Member and do not exclude yourself from the Class, you will be bound by the proceedings in the Action, including all past, present and future orders and judgments of the Court, whether favorable or unfavorable.

If you ask to be excluded from the Class, you will not be bound by any judgment in the Action, and you will not be eligible to receive a share of any money which might be recovered for the benefit of the Class. To exclude yourself from the Class, you must submit a written request for exclusion postmarked no later than March 1, 2013 in accordance with the instructions set forth in the full printed Notice. Pursuant to Rule 23(e)(4) of the Federal Rules of Civil Procedure, it is within the Court's discretion whether to allow a second opportunity to request exclusion from the Class if there is a settlement or judgment in the Action. The trial in the Action has been scheduled by the Court to begin on March 4, 2013.

Further information may be obtained by directing your inquiry in writing to the Notice Administrator.

BY ORDER OF THE COURT
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF NEW JERSEY


'/>"/>
SOURCE United States District Court for the District of New Jersey
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Analysis Confirms Albumin Preserves Kidney Function and Improves Survival in Common Abdominal Infection of Liver Disease
2. New Survey Affirms Compounding Pharmacies Vital Role in Public Health
3. Beth Israel Deaconess Medical Center, Harvard Medical School Study Confirms Cannabis Sciences Approach to Development of CS-TATI-1 to Inhibit Kaposi Sarcoma
4. Quest Diagnostics Confirms Investor Day on November 16
5. TUV Rheinland Confirms Apparent Fraud in Mislabeling of DRX Products Manufactured by HTRD and Excite Medical
6. Eaton Scientific Systems Confirms Acquisition and Status of Tropine 3 Patent Pending Non-Hormonal Treatment of Hot Flashes in Menopausal Women
7. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
8. Lilly Confirms Date and Conference Call for Second-Quarter 2012 Financial Results Announcement
9. Nouveau Life Pharmaceuticals (NOUV) In Talks with International Mass Distribution Firms
10. New Way for Life Science Firms to Find Partners
11. Study Confirms Daniels Sharpsmart Helps Hospitals Reduce Carbon Footprint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  Newly published research from ... Institute emphasizes the role a private retailer can play ... The study, published online today in the American ... decision to remove tobacco from all CVS Pharmacy stores ... settings with an even greater impact on those who ...
(Date:2/16/2017)... Summary Provides understanding and access to the allergy partnering ... ... Global Allergy Partnering Terms and Agreements since 2010 report provides understanding ... world,s leading healthcare companies. - Trends in partnering ... by company A-Z, industry sector, stage of development, technology type ...
(Date:2/16/2017)... Research and Markets has announced the addition of the ... Application, Cancer Type, Technology - Forecast to 2025" report to ... ... at a CAGR of around 28.6% over the next decade to ... of the prominent trends that the market is witnessing include increasing ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... While EHR data has revolutionized ... an innovative workstation designed to reduce nursing fatigue while enhancing productivity. Based on ... offers a lightweight, highly mobile, multi-functional alternative to the limitations of handheld computing. ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Feb. 22, 2017 — 1:30 p.m. – 2:30 p.m. ET, http://www.fdanews.com/deviceapproval ... asking before selecting an FDA approval pathway? , How should they evaluate ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the ... the most widely used electronic patient signatures solution in healthcare . ...
(Date:2/17/2017)... ... 17, 2017 , ... PrideStaff, a national staffing organization, is ... Staffing Industry Analysts' 2017 "Staffing 100 North America" list. , Now in ... to the staffing industry over the last twelve months. Industry insiders and observers ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... services and financial planning assistance to families and business owners in and around ... a charity drive to help prevent all forms of domestic violence. , There ...
Breaking Medicine News(10 mins):